Fasching, P. A., Loibl, S., Hu, C., Hart, S. N., Shimelis, H., Moore, R., . . . Couch, F. J. (2018). BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study. J Clin Oncol.
Trích dẫn kiểu ChicagoFasching, Peter A., et al. "BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study." J Clin Oncol 2018.
Trích dẫn MLAFasching, Peter A., et al. "BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study." J Clin Oncol 2018.